gastric%20cancer
GASTRIC CANCER
Gastric cancer is the cancer originating in the esophagus, esophagogastric junction and stomach.
Most of gastric cancers are adenocarcinomas, subdivided according to histological appearances into diffuse (undifferentiated) and intestinal (well differentiated) types.
It is the 4th most common cancer and the 2nd most common cause of cancer-related deaths worldwide.
Most common sites of gastric cancer are the proximal lesser curvature, cardia and esophagogastric junction.

Gastric Cancer References

  1. Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11(5):531-546. Accessed 28 Jan 2014. PMID: 23667204
  2. Waddell T, Verheji M, Allum W, et al. Gastric cancer: ESMO-ESSO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 Oct;24(Suppl 6):vi57-vi63. doi: 10.1093/annonc/mdt344. Accessed 28 Jan 2014. PMID: 24078663
  3. American Cancer Society. Stomach Cancer. American Cancer Society. http://www.cancer.org/.
  4. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: gastric cancer (including cancer in the proximal 5 cm of the stomach) version 2.2013. National Comprehensive Cancer Network. http://www.nccn.org/.
  5. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: gastric cancer version 1.2014. National Comprehensive Cancer Network. http://www.nccn.org/.
  6. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101-112. doi: 10.1007/s1020-011-0041-5. Accessed 9 Sep 2014. PMID: 21573743
  7. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: gastric cancer version 1.2015. NCCN web site. http://www.nccn.org/. 08 Jan 2015. Accessed 18 Feb 2015.
  8. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: gastric cancer version 3.2016. NCCN website. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf. Aug 2016.
  9. Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016 Sep;27(Suppl 5):v38-v49. https://annonc.oxfordjournals.org/. Accessed 03 Nov 2016. PMID: 27664260
  10. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: gastric cancer version 3.2015. NCCN. http://www.nccn.org/. 23 Mar 2015. Accessed 31 Mar 2016.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 24 Jan 2020
Use of adalimumab or infliximab in biologic-naïve patients with inflammatory bowel disease (IBD) delivers comparable rates of corticosteroid-free remission, as shown by a study presented at the Advances in Inflammatory Bowel Disease (AIBD) Conference 2019.